New Study: Why Do Integrated Fat Transfer Systems Have a Higher Revenue Share | Report Fact.MR
The global autologous fat grafting market is projected to grow at a healthy CAGR of 10% through 2031. Increasing demand for non-invasive and minimally-invasive procedures has been accelerating the demand for autologous fat grafting procedures. Rising inclination among youth for the correction of contour deformities and towards breast augmentation is driving the growth of market.
According to the study, breast augmentation is expected to dominate the market. Breast augmentation is one of the top performed cosmetic surgeries across the globe. Advancement in technology and innovation in grafting procedures have increased the demand for breast augmentation.
Furthermore, rising prevalence of skin disorders and scars due to burns or accidents are creating opportunities for autologous fat grafting providers. Rising demand for breast augmentation across the U.S., Brazil, and UK is creating lucrative opportunities for autologous fat grafting manufacturers.
For more Insights into the Market, Request a Sample of this Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=2701
According to American Society of Plastic Surgeons an increasing number of women in the United States undergo breast augmentation procedures. In 2020, 18.1 million cosmetic procedures were recorded in United States, among those breast augmentation continues to be top cosmetic surgical procedure.
“Rising demand for cosmetic procedure and favorable reimbursement policies by government are spurring the autologous fat grafting market” says a Fact.MR analyst.
Key Takeaways
- In terms of product, integrated fat transfer systems to account for 55% of total market share
- Breast augmentation expected to hold over 45% of market share
- United States to lead the North American autologous fat grafting market backed by technological advancements and R&D activities in the region
- UK and Germany to expand at the rate of 10% CAGR each through 2031
- Brazil is expected to emerge as a lucrative market due to the rising breast augmentation procedures through 2021
- Growing number of cosmetic procedure to improve the growth in Japan
- Hospitals to account for nearly half of the total market share
Competitive Landscape
Prominent players operating in the global autologous fat grafting market profiled by Fact.MR include AbbVie Inc., Sisram Medical Limited, Plus Therapeutics Inc., Genesis Biosystems Inc., Black Tie Medical Inc., Ranfac Corp., HK Surgical Inc., MicroAire Surgical Instruments LLC, Innovia Medical Inc., Human Med AG, Sterimedix Ltd., Proteal Bio regenerative Solutions and Lipogems International SPA among others. Leading players are developing innovative products incorporating advanced technology to retain and increase their market share.
For instance, in April 2019, Alma, a Sisram Medical Company announced the launch of BeautiFill, the first laser-based platform to produce high quality autologous fat for holistic body and face contouring with the added benefits of reducing surgical procedure time and associated risk.
Also, in 2020, medical device company GC Aesthetics launched its next generation of GCA breast implants, PERLE.
Get Customization on this Report for Specific Country
https://www.factmr.com/connectus/sample?flag=RC&rep_id=2701
More Valuable Insights on Autologous fat grafting market
Fact.MR has published a latest market research report on global autologous fat grafting market for the period 2021-2031. The study gives a detailed segmentation on the trends, challenges and drivers of the market expected to prevail in the upcoming years. In order to gain a better understanding, the market is segmented on the basis of product (integrated fat systems, aspiration & harvesting systems, liposuction systems, fat processing systems, de-epithelialization devices, and accessories), application (breast augmentation, buttock augmentation, facial fat grafting, hand rejuvenation, and others), end-user (hospitals, on-site clinics, and plastic surgery centers), and regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and MEA).
Key Questions Covered in the Report
- How will demand for autologous fat grafting market will evolve in the future?
- Which are the lucrative markets for autologous fat grafting market?
- How will changing trends impact the strategies of market players?
- Which is the most lucrative segment of the autologous fat grafting market?
- Which are the top players operating in the market?
- What is the impact of Covid-19 on autologous fat grafting market?
Read Fact.MR Exclusive Article on Emerging Frontiers in the Global Dental Industry
https://www.factmr.com/article/110/emerging-frontiers-in-the-global-dental-industry
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Neha Bhosle
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Media Contact
Company Name: Fact.MR
Contact Person: Neha Bhosle
Email: Send Email
Phone: 6282511583
Address:US Sales Office: 11140 Rockville Pike
City: Rockville
State: Maryland
Country: United States
Website: https://www.factmr.com
